USB459408I5 - - Google Patents
Info
- Publication number
- USB459408I5 USB459408I5 US45940874A USB459408I5 US B459408 I5 USB459408 I5 US B459408I5 US 45940874 A US45940874 A US 45940874A US B459408 I5 USB459408 I5 US B459408I5
- Authority
- US
- United States
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
- C07D231/52—Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/633,601 US4045571A (en) | 1973-04-17 | 1975-11-20 | Pyrazol-5-ones |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DT2319278 | 1973-04-17 | ||
DE2319278A DE2319278C2 (en) | 1973-04-17 | 1973-04-17 | Pharmaceutical agent |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US05/633,601 Division US4045571A (en) | 1973-04-17 | 1975-11-20 | Pyrazol-5-ones |
US05633636 Division | 1975-11-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
USB459408I5 true USB459408I5 (en) | 1976-03-23 |
US4018890A US4018890A (en) | 1977-04-19 |
Family
ID=5878313
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US05/459,408 Expired - Lifetime US4018890A (en) | 1973-04-17 | 1974-04-09 | Pyrazol-5-one pharmaceutical compositions and methods for effecting diuresis, saluresis and for treating hypertension |
US06/102,840 Expired - Lifetime US4288446A (en) | 1973-04-17 | 1979-12-12 | Pyrazol-5-ones |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US06/102,840 Expired - Lifetime US4288446A (en) | 1973-04-17 | 1979-12-12 | Pyrazol-5-ones |
Country Status (11)
Country | Link |
---|---|
US (2) | US4018890A (en) |
BE (1) | BE813745A (en) |
DE (1) | DE2319278C2 (en) |
FR (1) | FR2226169B1 (en) |
GB (1) | GB1434171A (en) |
IE (1) | IE39211B1 (en) |
IL (1) | IL44625A (en) |
LU (1) | LU69870A1 (en) |
NL (1) | NL178564C (en) |
PH (1) | PH10818A (en) |
ZA (1) | ZA742383B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4053621A (en) | 1974-06-06 | 1977-10-11 | Bayer Aktiengesellschaft | 1-[2-(βNaphthyloxy)ethyl]-3-methylpyrazolone-(5) and antithrombotic and antithrombolytic compositions and methods utilizing them |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1229553A (en) * | 1983-05-18 | 1987-11-24 | Edmund Y. Lukevits | Pharmaceutical preparation for the treatment of hypertensive disease and myocardial infarction |
DE3436383A1 (en) * | 1984-10-04 | 1986-04-10 | Bayer Ag, 5090 Leverkusen | METHOD FOR PRODUCING PYRAZOLONE DERIVATIVES |
USRE35801E (en) * | 1985-05-20 | 1998-05-19 | Mitsubishi Chemical Corporation | Prophylactic and therapeutic composition for circulatory disorders and method of treatment |
DK169672B1 (en) * | 1985-05-20 | 1995-01-09 | Mitsubishi Chem Ind | Pharmaceutical preparations containing pyrazolone derivatives as active ingredient and the use of pyrazolone derivatives for the preparation of pharmaceutical preparations |
DE3626908A1 (en) * | 1986-08-08 | 1988-02-11 | Bayer Ag | PARENTERAL SOLUTION |
ATE502635T1 (en) | 2002-08-19 | 2011-04-15 | Pfizer | COMBINATION THERAPY AGAINST HYPERPROLIFERATIVE DISEASES |
US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
WO2008070496A2 (en) | 2006-12-01 | 2008-06-12 | Bristol-Myers Squibb Company | N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
EP2986599A1 (en) | 2013-04-17 | 2016-02-24 | Pfizer Inc. | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases |
US9573122B2 (en) * | 2014-08-29 | 2017-02-21 | Chevron U.S.A. Inc. | Small crystal LTL framework type zeolites |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
US11248001B2 (en) | 2019-01-18 | 2022-02-15 | Astrazeneca Ab | PCSK9 inhibitors and methods of use thereof |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3147276A (en) * | 1964-09-01 | Pyrazolones | ||
US2376380A (en) * | 1945-05-22 | Preparation of amino pyrazolones | ||
US2476986A (en) * | 1949-07-26 | Elmobe louis martin | ||
US2476987A (en) * | 1949-07-26 | S-acyloxy pyrazqles and method foe | ||
GB559919A (en) * | 1942-09-07 | 1944-03-10 | Lamson Engineering Co | Improvements in and relating to pneumatic tube conveyor systems |
GB636988A (en) * | 1947-12-24 | 1950-05-10 | Gevaert Photo Producten Naamlo | Improvements in and relating to the production of colour photographic images |
US2511231A (en) * | 1949-03-26 | 1950-06-13 | Eastman Kodak Co | 1-cyanophenyl-3-acylamino-5-pyrazolone couplers for color photography |
US2600788A (en) * | 1949-06-07 | 1952-06-17 | Eastman Kodak Co | Halogen-substituted pyrazolone couplers for color photography |
ZA10401B (en) * | 1949-08-22 | |||
US2672417A (en) * | 1949-12-31 | 1954-03-16 | Gevaert Photo Prod Nv | Production of color photographic images |
GB779703A (en) * | 1953-07-06 | 1957-07-24 | Hoechst Ag | Pyrazolone compounds and a process for making them |
US2848446A (en) * | 1954-02-23 | 1958-08-19 | Saul & Co | Azo dyestuffs |
DE1003215B (en) * | 1954-08-07 | 1957-02-28 | Hoechst Ag | Process for the preparation of 1-benzyl-3-methyl-pyrazolone- (5) |
US3014916A (en) * | 1959-01-22 | 1961-12-26 | May & Baker Ltd | Pyrazole derivatives |
GB935538A (en) * | 1959-04-06 | 1963-08-28 | Stop Motion Devices Corp | Stop-motion head for use on knitting machines |
GB961037A (en) * | 1960-08-23 | 1964-06-17 | Smith & Nephew | Pyrazolones and processes for their preparation |
NL279140A (en) * | 1961-05-31 | |||
US3190888A (en) * | 1963-08-22 | 1965-06-22 | American Home Prod | Aryloxyalkylpyrazole |
DE1670529C3 (en) * | 1966-07-13 | 1974-01-10 | Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt | Substituted s-triazines |
GB1190914A (en) * | 1966-09-26 | 1970-05-06 | Agfa Gevaert Nv | 2-Pyrazolin-5-Ones and the use thereof as Colour Couplers |
FR1558513A (en) * | 1968-01-04 | 1969-02-28 | ||
GB1247688A (en) * | 1968-02-26 | 1971-09-29 | Agfa Gevaert | Monomeric and polymeric 2-pyrazoline-5-one colour couplers |
JPS4818858B1 (en) * | 1969-04-07 | 1973-06-08 | ||
FR2068413A1 (en) * | 1969-10-22 | 1971-08-27 | Synthelabo | 1-alkyl-3-alkylamino-5-aryl-pyrazolines hypo-and hypertensives |
US3615506A (en) * | 1970-02-09 | 1971-10-26 | Eastman Kodak Co | Silver halide emulsions containing 3-cyclicamino-5-pyrazolone color couplers |
US3694456A (en) * | 1970-05-08 | 1972-09-26 | Takeda Chemical Industries Ltd | 1-disubstituted aminopyrazoles |
FR2101060B1 (en) * | 1970-08-14 | 1974-02-01 | Roussel Uclaf | |
FR2104931B1 (en) * | 1970-09-08 | 1975-01-10 | Ferlux | |
JPS548689B1 (en) * | 1970-12-04 | 1979-04-18 | ||
JPS5417772B1 (en) * | 1970-12-04 | 1979-07-03 | ||
DE2230792A1 (en) * | 1972-06-23 | 1974-01-17 | Bayer Ag | 3-AMINO-PYRAZOLONE- (5), METHOD FOR MANUFACTURING AND USING IT AS A MEDICINAL PRODUCT |
DE2230675A1 (en) * | 1972-06-23 | 1974-01-10 | Bayer Ag | DIURETIC AND ANTIHYPERTENSIVE AGENT |
AR207445A1 (en) * | 1973-04-17 | 1976-10-08 | Bayer Ag | PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF PIRAZOLONES- (5) -1-SUBSTITUTED |
-
1973
- 1973-04-17 DE DE2319278A patent/DE2319278C2/en not_active Expired
-
1974
- 1974-03-29 FR FR7411442A patent/FR2226169B1/fr not_active Expired
- 1974-04-02 PH PH15695A patent/PH10818A/en unknown
- 1974-04-09 US US05/459,408 patent/US4018890A/en not_active Expired - Lifetime
- 1974-04-12 IL IL44625A patent/IL44625A/en unknown
- 1974-04-16 ZA ZA00742383A patent/ZA742383B/en unknown
- 1974-04-16 LU LU69870A patent/LU69870A1/xx unknown
- 1974-04-16 GB GB1650974A patent/GB1434171A/en not_active Expired
- 1974-04-16 NL NLAANVRAGE7405114,A patent/NL178564C/en not_active IP Right Cessation
- 1974-04-16 BE BE143221A patent/BE813745A/en not_active IP Right Cessation
- 1974-04-17 IE IE797/74A patent/IE39211B1/en unknown
-
1979
- 1979-12-12 US US06/102,840 patent/US4288446A/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4053621A (en) | 1974-06-06 | 1977-10-11 | Bayer Aktiengesellschaft | 1-[2-(βNaphthyloxy)ethyl]-3-methylpyrazolone-(5) and antithrombotic and antithrombolytic compositions and methods utilizing them |
Also Published As
Publication number | Publication date |
---|---|
FR2226169B1 (en) | 1978-07-28 |
IE39211L (en) | 1974-10-17 |
US4288446A (en) | 1981-09-08 |
PH10818A (en) | 1977-09-08 |
BE813745A (en) | 1974-10-16 |
LU69870A1 (en) | 1974-11-21 |
AU6793474A (en) | 1975-10-16 |
FR2226169A1 (en) | 1974-11-15 |
NL178564C (en) | 1986-04-16 |
IE39211B1 (en) | 1978-08-30 |
DE2319278C2 (en) | 1986-02-20 |
DE2319278A1 (en) | 1974-11-07 |
NL7405114A (en) | 1974-10-21 |
ZA742383B (en) | 1975-04-30 |
IL44625A0 (en) | 1974-06-30 |
NL178564B (en) | 1985-11-18 |
GB1434171A (en) | 1976-05-05 |
IL44625A (en) | 1978-07-31 |
US4018890A (en) | 1977-04-19 |